Details of the KEYNOTE-189 study have been announced by Merck (known as MSD outside the United States and Canada).
A study led by researchers at The Institute of Cancer Research (London, UK) has uncovered numerous ways of targeting prostate cancer.
Keep checking back throughout the conference, we will be updating this article with the biggest news headlines from the American Association for Cancer Research (AACR) Annual Meeting 2018 (April 14–18, IL, USA).
What advancements have we witnessed in the field of immunotherapy for lung cancer and what does the future of this field look like? Find out in this article from Lung Cancer Management.
Discover cases studies of rare recurrences after adjuvant chemotherapy in this Editorial from Future Oncology.
Discover a comprehensive view of the molecular mechanisms involved in colorectal cancer pathogenesis.